Bacteriophage T7, a virus that preys on E. coli, becomes a more effective killer after spending time aboard the International ...

The research, published in Science Advances, brought together scientists from Otago and the Okinawa Institute of Science and Technology. The team closely examined the molecular structure of Bas63, a ...

Scientists Meet in Valencia to Define the Path to Clinical Integration Valencia, Spain. June 9–10, 2026 Researchers, clinicians, and biotechnology innovators from around the world will gather in ...

As antimicrobial resistance (AMR) continues to threaten global health, NRC researchers are engineering innovative solutions that could redefine how we fight infections. Before the COVID-19 pandemic, ...

Detailed price information for Armata Pharmaceuticals Inc (ARMP-A) from The Globe and Mail including charting and trades.

Intravenous use as a QIDP for adjunct treatment of complicated bacteremia caused by Staphylococcus aureus QIDP Designation provides for five years of market exclusivity ...

UMC Utrecht has received a grant of 4 million euros for the first clinical study in the Netherlands involving a customized therapy with bacteriophages for patients with recurrent urinary tract ...

Phage therapy is an emerging strategy that uses viruses that target bacteria to restore gut balance and treat microbiome-related diseases. Ongoing research and early trials show promise, but ...

This 2009 electron microscope image provided by the Centers for Disease Control and Prevention shows a large group of Gram-negative Salmonella typhimurium bacteria that had been isolated from a pure ...

Highly pathogenic avian influenza A (H5N1, commonly known as HPAI or bird flu) is a formidable worldwide public health concern. With approximately a 100% mortality rate, the World Organization for ...